Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
British Journal of Clinical Pharmacology
|
September 14, 2021
Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach
Stephan Schaller, Frederico S Martins, Pavel Balazki, et al.
Plastic and Reconstructive Surgery
|
August 29, 2002
Incorporation of titanium mesh in orbital and midface reconstruction
Warren Schubert, Andrew J L Gear, Chen Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006
R A Hilger, S Kredke, D Hedley, et al.
JAMA Facial Plastic Surgery
|
March 31, 2017
Comparison of Neurovascular Characteristics of Facial Skin in Patients After Primary and Revision Rhytidectomies
Farhad Ardeshirpour, Elisabeth Hurliman, Gwen Wendelschafer-Crabb, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors
H Richly, P Kupsch, K Passage, et al.
British Journal of Cancer
|
May 29, 2008
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
A C Pieck, A Drescher, K G Wiesmann, et al.
Blood
|
July 13, 2006
Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model
Ina Rattmann, Veronika Kleff, Ursula R Sorg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial
H Richly, B Schultheis, I A Adamietz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 12, 2007
Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines
B Neugebauer, C Drai, M Haase, et al.
Drug Metabolism and Pharmacokinetics
|
July 23, 2023
Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation
Xieran Li, Krzysztof Kalwak, Rita Beier, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
British Journal of Clinical Pharmacology
|
September 14, 2021
Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach
Stephan Schaller, Frederico S Martins, Pavel Balazki, et al.
Plastic and Reconstructive Surgery
|
August 29, 2002
Incorporation of titanium mesh in orbital and midface reconstruction
Warren Schubert, Andrew J L Gear, Chen Lee, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 31, 2002
ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006
R A Hilger, S Kredke, D Hedley, et al.
JAMA Facial Plastic Surgery
|
March 31, 2017
Comparison of Neurovascular Characteristics of Facial Skin in Patients After Primary and Revision Rhytidectomies
Farhad Ardeshirpour, Elisabeth Hurliman, Gwen Wendelschafer-Crabb, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2003
A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors
H Richly, P Kupsch, K Passage, et al.
British Journal of Cancer
|
May 29, 2008
Oxaliplatin-DNA adduct formation in white blood cells of cancer patients
A C Pieck, A Drescher, K G Wiesmann, et al.
Blood
|
July 13, 2006
Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model
Ina Rattmann, Veronika Kleff, Ursula R Sorg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2008
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: results from a phase I extension trial
H Richly, B Schultheis, I A Adamietz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 12, 2007
Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines
B Neugebauer, C Drai, M Haase, et al.
Drug Metabolism and Pharmacokinetics
|
July 23, 2023
Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation
Xieran Li, Krzysztof Kalwak, Rita Beier, et al.
Page
of 15